PTC Therapeutics, Inc. announced that on April 13, 2021 it approved non-statutory stock options to purchase an aggregate of 75,085 shares of its common stock and 33,740 restricted stock units, each representing the right to receive one share of its common stock upon vesting, to 79 new employees.
April 19, 2021
· 2 min read